Home › Urothelial (Transitional Cell) Carcinoma › Michigan › Grand Rapids
Urothelial (Transitional Cell) Carcinoma clinical trials in Grand Rapids, MI
5 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Grand Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- South Texas Accelerated Research Therapeutics (START), Grand Rapids
DBC-664 in Adult Patients With Solid Tumors
RecruitingPhase 1
- START Midwest, Grand Rapids
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
RecruitingPhase 2/3
- Research Site, Grand Rapids
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecruitingPhase 2
- The Cancer & Hematology Centers, Grand Rapids
- Cancer & Hematology Centers of Western Michigan, PC- Kit Storage, Grand Rapids
- The Cancer & Hematology Centers, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RecruitingPhase 1/2
- START Midwest, Grand Rapids
Urothelial (Transitional Cell) Carcinoma trials in other cities
- Nashville, TN23 studies
- New York City, NY22 studies
- Houston, TX19 studies
- Dallas, TX18 studies
- Edison, NJ18 studies
- Los Angeles, CA17 studies
- Queens, NY15 studies
- Chicago, IL14 studies
- Arlington, VA12 studies
- Boston, MA11 studies
- San Antonio, TX11 studies
- Austin, TX10 studies
Other studies in Grand Rapids
- Non-Small Cell Lung Cancer44 studies
- Colorectal Cancer40 studies
- Cancer (all types)28 studies
- Breast Cancer26 studies
- Ovarian Cancer24 studies
- Metastatic Cancer22 studies
- Prostate Cancer19 studies
- Endometrial Cancer18 studies
- Stomach Cancer18 studies
- Pancreatic Cancer18 studies
- Melanoma17 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.